116 related articles for article (PubMed ID: 34294655)
1. Does Hyperlipasemia Predict Worse Clinical Outcomes in COVID-19? A Multicenter Retrospective Cohort Study.
Singh RR; Chhabra P; Kumta NA
J Clin Gastroenterol; 2022 Mar; 56(3):e227-e231. PubMed ID: 34294655
[TBL] [Abstract][Full Text] [Related]
2. Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease.
Ahmed A; Fisher JC; Pochapin MB; Freedman SD; Kothari DJ; Shah PC; Sheth SG
Pancreatology; 2021 Jun; 21(4):698-703. PubMed ID: 33741267
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Outcomes in COVID-19 Patients With Varying Degrees of Hyperlipasemia.
Benias PC; Inamdar S; Wee D; Liu Y; Buscaglia JM; Satapathy SK; Trindade AJ;
Pancreas; 2021 Oct; 50(9):1310-1313. PubMed ID: 34860817
[TBL] [Abstract][Full Text] [Related]
4. Lipase elevation on admission predicts worse clinical outcomes in patients with COVID-19.
Kiyak M; Düzenli T
Pancreatology; 2022 Jun; 22(5):665-670. PubMed ID: 35537935
[TBL] [Abstract][Full Text] [Related]
5. Non-pancreatic hyperlipasemia: A puzzling clinical entity.
Feher KE; Tornai D; Vitalis Z; Davida L; Sipeki N; Papp M
World J Gastroenterol; 2024 May; 30(19):2538-2552. PubMed ID: 38817657
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of patients with acute pancreatitis associated with SARS-CoV-2 (COVID-19); The importance of lipase/lymphocyte ratio in predicting mortality.
Haydar FG; Otal Y; Avcioglu G
Bratisl Lek Listy; 2022; 123(6):428-434. PubMed ID: 35576544
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States.
Raiker R; DeYoung C; Pakhchanian H; Ahmed S; Kavadichanda C; Gupta L; Kardeş S
Semin Arthritis Rheum; 2021 Oct; 51(5):1057-1066. PubMed ID: 34450504
[TBL] [Abstract][Full Text] [Related]
10. Development of pancreatic injuries in the course of COVID-19.
Akkus C; Yilmaz H; Mizrak S; Adibelli Z; Akdas O; Duran C
Acta Gastroenterol Belg; 2020; 83(4):585-592. PubMed ID: 33321015
[TBL] [Abstract][Full Text] [Related]
11. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study.
Tuan WJ; Spotts H; Zgierska AE; Lennon RP
BMJ Open; 2021 Nov; 11(11):e056436. PubMed ID: 34836910
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Injury in COVID-19 Patients.
Bansal P; Margekar SL; Suman V; Sud R; Meena S; Sharma AK; Islam SY; Gurtoo A; Agrawal A; Pangtey GS; Prakash A
J Assoc Physicians India; 2020 Dec; 68(12):58-60. PubMed ID: 33247644
[TBL] [Abstract][Full Text] [Related]
14. Lipase Elevation in Patients With COVID-19.
McNabb-Baltar J; Jin DX; Grover AS; Redd WD; Zhou JC; Hathorn KE; McCarty TR; Bazarbashi AN; Shen L; Chan WW
Am J Gastroenterol; 2020 Aug; 115(8):1286-1288. PubMed ID: 32496339
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
16. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value.
Caruso S; Aloisio E; Dolci A; Panteghini M
Clin Chem Lab Med; 2022 Jan; 60(1):135-142. PubMed ID: 34687597
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and short-term outcomes of acute pancreatitis among patients with COVID-19.
Zhang J; Luo D; Kang M; Li B; Su S
Eur J Med Res; 2023 Aug; 28(1):283. PubMed ID: 37582798
[TBL] [Abstract][Full Text] [Related]
18. Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19.
Kaminsky LW; Dalessio S; Al-Shaikhly T; Al-Sadi R
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3629-3637.e2. PubMed ID: 34293501
[TBL] [Abstract][Full Text] [Related]
19. Virus related acute pancreatitis and virus superinfection in the 'Dual disease' model of acute pancreatitis and SARS-Co-V2 infection: A multicentre prospective study.
Samanta J; Mahapatra SJ; Kumar N; Elhence A; Dhar J; Gupta A; Dhooria A; Bhalla A; Prasad M; Das A; Sharma R; Kochhar R; Garg PK;
Pancreatology; 2022 Apr; 22(3):339-347. PubMed ID: 35131169
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
